Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Change In Receivables : HK$308 Mil (TTM As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Chunlizhengda Medical Instruments Co Change In Receivables?

Beijing Chunlizhengda Medical Instruments Co's change in receivables for the quarter that ended in Jun. 2024 was HK$13 Mil. It means Beijing Chunlizhengda Medical Instruments Co's Accounts Receivable declined by HK$13 Mil from Dec. 2023 to Jun. 2024 .

Beijing Chunlizhengda Medical Instruments Co's change in receivables for the fiscal year that ended in Dec. 2023 was HK$323 Mil. It means Beijing Chunlizhengda Medical Instruments Co's Accounts Receivable declined by HK$323 Mil from Dec. 2022 to Dec. 2023 .

Beijing Chunlizhengda Medical Instruments Co's Accounts Receivable for the quarter that ended in Jun. 2024 was HK$377 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Beijing Chunlizhengda Medical Instruments Co's Days Sales Outstanding for the six months ended in Jun. 2024 was 167.91.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Beijing Chunlizhengda Medical Instruments Co's liquidation value for the six months ended in Jun. 2024 was HK$1,860 Mil.

Beijing Chunlizhengda Medical Instruments Co Change In Receivables Historical Data

The historical data trend for Beijing Chunlizhengda Medical Instruments Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Chunlizhengda Medical Instruments Co Change In Receivables Chart

Beijing Chunlizhengda Medical Instruments Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-152.38

-133.31

-275.60

-460.27

322.50

Beijing Chunlizhengda Medical Instruments Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Change In Receivables	Get a 7-Day Free Trial															-258.49	-214.02	26.72	295.79	12.70

Beijing Chunlizhengda Medical Instruments Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$308 Mil.

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Beijing Chunlizhengda Medical Instruments Co's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	376.509	/	409.228	*	91
=	167.91

2. In Ben Graham's calculation of liquidation value, Beijing Chunlizhengda Medical Instruments Co's accounts receivable are only considered to be worth 75% of book value:

Beijing Chunlizhengda Medical Instruments Co's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2173.533	-	875.835	+	0.75 * 376.509	+	0.5 * 560.231
=	1,860

Beijing Chunlizhengda Medical Instruments Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Beijing Chunlizhengda Medical Instruments Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Chunlizhengda Medical Instruments Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Chunlizhengda Medical Instruments Co Ltd (HKSE:01858) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

688236:China

Address

No. 10 Xinmi Xi Er Road, Southern District of Tongzhou, Economic Development Zone, Tongzhou District, Beijing, CHN

Website

http://www.clzd.com

Beijing Chunlizhengda Medical Instruments Co Ltd is an orthopedic medical device company. It is engaged in the research, development, manufacture, and sale of orthopedic medical devices, including joint prosthesis products and spinal products. The products offered by the company are Standard joint prosthesis products, Custom joint prosthesis products, Spinal products, Sports medicine products, oral products, Platelet Rich Plasma Products, Yangtze River INS-intelligent robot and others. It operates in the business segment of manufacture and trading of surgical implants, instruments and related products.

Executives

Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co.	2502 Approved lending agent
Citigroup Inc.	2502 Approved lending agent
Fidelity China Special Situations Plc	2101 Beneficial owner
Taiping Assets Management (hk) Company Limited	2102 Investment manager
Taiping Trustees Limited	2301 Trustee

Beijing Chunlizhengda Medical Instruments Co Headlines

No Headlines